Measurement of human IGF-II using Sephacryl extraction: A rapid and reliable assay method

Annals of Clinical Biochemistry

Volumn 33, Issue 3, 1996, Pages 201-208

  Mason, Barbara H ^a   Tatnell, Michele A ^a   Holdaway, Ian M ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Chromatography; Growth hormone disorders; Human serum; Insulin like growth factor II

Indexed keywords

OVIS;

ACRYLIC ACID RESIN; DEXTRAN; SEPHADEX; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; RECOMBINANT SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; GEL; GEL CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; REPRODUCIBILITY; TIME; BLOOD LEVEL; EXTRACTION; HYPOPITUITARISM; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SHEEP; SHORT STATURE;

ACRYLIC RESINS; ADULT; AGED; CHROMATOGRAPHY, GEL; DEXTRANS; FEMALE; GELS; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0029948657     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300305     Document Type: Article

References (30)

1. Ron D, Powers AC, Pandian NR, Godine JE, Axlerod L. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumour-induced hypoglycaemia. J Clin Endocrinol Metab 1989; 68: 701-6
2. Jorgensen JOL, Blum WF, Moller N, Ranke MB, Christiansen JS. Short-term changes in insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 1991; 72: 582-7
3. Schofield PN, Lee A, Hill DJ, Cheetham JE, James D, Stewart C. Tumour suppression associated with expression of human insulin-like growth factor II. Br J Cancer 1991; 68: 687-92
4. Yee B, Cullen KJ, Paik S, Perdue JF, Hampton B, Shwartz K, et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 1988; 48: 6691-6
5. Manni A, Wei L, Badger B, Zaenglein A, Leighton J, Shimasaki S, et al. Expression of messenger RNA for insulin-like growth factors and insulin-like growth factor binding proteins by experimental breast cancer and normal breast tissue in vivo. Endocrinology 1992; 130: 1744-6
6. Rosen N, Yee D, Lippman ME, Park S, Cullen KJ. Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat 1991; 18: 555-62
7. Zapf J, Walter H, Froesch ER. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycaemia. J Clin Invest 1981; 68: 1321-30
8. Hintz RL, Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 1977; 45: 988-95
9. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid chromatographed uremic serum. J Clin Endocrinol Metab 1986; 63: 1186-92
10. Daughaday WH, Kapadia M, Mariz I. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J Lab Clin Med 1987; 109: 355-63
11. Bowsher RR, Lee WH, Apathy JM, O'Brien PJ, Ferguson AL, Henry DP. Measurement of insulin-like growth factor II in physiological fluids and tissues. 1. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 1991; 128: 805-14
12. Scott CD, Baxter RC. Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology 1986; 119: 2346-52
13. Crawford BA, Martin JL, Howe CJ, Handelsman DJ, Baxter RC. Comparison of extraction methods for insulin-like growth factor-I in rat serum. J Endocrinol 1992; 134: 169-76
14. Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 1980; 51: 781-8
15. Moore LG, Mylek ME. A novel method for the extraction of sheep insulin-like growth factors-I and -II from plasma prior to radioimmunoassay. J Endocrinol 1993; 137: 239-45
16. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regulat 1994; 4(1): 11-19
17. Koea JB, Breier BH, Shaw JHF, Gluckman PD. A possible role for IGF-II: evidence for in vivo regulation of IGF-I mediated protein anabolism. Endocrinology 1992; 130: 2423-5
18. Greenwood FC, Hunter WH, Glover JS. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114-23
19. Linde S, Hansen B, Lernmark A. Stable iodinated polypeptide hormones prepared by polyacrylamide gel electrophoresis. Anal Biochem 1980; 107(1): 165-76
20. Simmons D. Differences in umbilical cord insulin and birth weight in non-diabetic pregnancies of women from different ethnic groups in New Zealand. Diabetologia 1994; 37: 930-6
21. Gluckman PD, Johnson-Barret TJ, Butler J, Edgar BW, Gunn TR. Studies of insulin-like growth factors-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol 1983; 19: 405-13
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 292: 307-10
23. Blum WF, Gallaher B, Ranke MB. An IGFBP-blocked IGF-I RIA that measures what it pretends to measure: IGF-I[Abstract]. In: 74th Annual Meeting of the American Endocrine Society. USA: American Endocrine Society, 1992: 293
24. Owens PC, Johnson RJ, Campbell RG, Ballard FJ. Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J Endocrinol 1990; 124: 269-75
25. Owens JA, Kind KL, Carbone F, Robinson JS, Owens PC. Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth. J Endocrinol 1994; 140: 5-13
26. Lord AP, Read LC, Owens PC, Martin AA, Wallon PE, Ballard FJ. Rapid changes in plasma concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IGF-binding proteins during anaesthesia in young sheep. J Endocrinol 1994; 141: 427-37
27. Quirk P, Owens P, Moyse K, Chin S, Wall C, Ballard J, et al. Insulin-like growth factors I and II are reduced in plasma from growth retarded children with chronic liver disease. Growth Regul 1994; 4(1): 35-8
28. Deyssig R, Frisch H, Blum WF, Waldhor T. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol 1993; 128: 313-18
29. Kubota T, Kamada S, Taguchi M, Aso T. Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinol 1992; 127: 359-65
30. Holdaway IM, Mason BH. Hormonal factors in the regulation of growth of breast cancer [Abstract 515]. In: Proceedings of the 10th Asia and Oceania Congress of Endocrinology Beijing, Oct 30 Nov 3; China: AOCE, 1994: 37